The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 11, Pages 1822
Publisher
MDPI AG
Online
2017-10-26
DOI
10.3390/molecules22111822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processes
- (2017) Liyan Ji et al. Oncotarget
- Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells
- (2016) Jingyun Yao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
- (2016) Vlasta Němcová-Fürstová et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms
- (2016) L Wang et al. Cell Death & Disease
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Changed expression and function of P-gp in peripheral blood CD56 + cells predicting chemoresistance in non-Hodgkin lymphoma patients
- (2015) Li Han et al. Cancer Biomarkers
- Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis
- (2015) Xiaoqian Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer
- (2015) Kyoichi Kaira et al. International Journal of Clinical Oncology
- Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
- (2013) W.J. Sheng et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy
- (2013) K. Yuan et al. CLINICAL CANCER RESEARCH
- 7b, a novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted-inhibiting TAK1 following down-regulation of ERK1/2- and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages
- (2013) Jin Shao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Sequential Targeted Delivery of Paclitaxel and Camptothecin Using a Cross-Linked “Nanosponge” Network for Lung Cancer Chemotherapy
- (2013) Ghazal Hariri et al. MOLECULAR PHARMACEUTICS
- BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling
- (2013) M Sung et al. ONCOGENE
- 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway
- (2012) Song-qiang Xie et al. APOPTOSIS
- Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells
- (2012) Hengrui Zhu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
- (2012) Wu-Chou Su et al. International Journal of Nanomedicine
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells
- (2011) Vidya Mamidipudi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells via Down-Regulating P-gp
- (2011) Xulong Zhang et al. PLoS One
- Sulforaphane Inhibits Constitutive and Interleukin-6-Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells
- (2010) E. R. Hahm et al. Cancer Prevention Research
- Reactive oxygen species involved in sulforaphane-induced STAT3 inactivation and apoptosis in DU145 prostate cancer cells
- (2010) Wonil Koh et al. CHINESE SCIENCE BULLETIN
- Overview of Naphthalimide Analogs as Anticancer Agents
- (2009) Min Lv et al. CURRENT MEDICINAL CHEMISTRY
- PARP inhibition during alkylation-induced genotoxic stress signals a cell cycle checkpoint response mediated by ATM
- (2009) Michael J. Carrozza et al. DNA REPAIR
- Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
- (2008) Shu-Feng Zhou et al. CURRENT MEDICINAL CHEMISTRY
- Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells
- (2008) A. Lacreusette et al. JOURNAL OF PATHOLOGY
- Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia
- (2008) M Burcu et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation